Strategies for Patient Adherence to Blood Pressure Management Therapies

Daniel Edmundowicz, MS, MD, FACP, FACC, Chief, Cardiology, Temple University Hospital discusses the challenges of maintaining long-term adherence of preventative medications for hypertension. Antihypertensives and lipid-lowering medications have the highest rates of non-initiation; only about half of patients in a particular study remained on their medications for two years. Combine this with another adherence issue – taking the correct dose at the correct time – and it’s easy to see why nonadherence is a major barrier to patients meeting their blood pressure goals.


With the Temple Comprehensive Hypertension Program, a multidisciplinary team works with patients to understand suboptimal adherence and the factors that lead to it, while also helping them to develop strategies to improve adherence and ultimately reach their target blood pressure goals.

Created by

Temple Health


Daniel Edmundowicz, MS, MD, FACP, FACC

Daniel Edmundowicz, MS, MD, FACP, FACC

Chair, Department of Medicine, Lewis Katz School of Medicine at Temple University

Florence P. Bernheimer Distinguished Service Professorship Chair, Cardiology

View full profile